Copyright
©The Author(s) 2023.
World J Gastroenterol. Nov 7, 2023; 29(41): 5683-5698
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5683
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5683
Figure 6 Sensitivity of CBC2T-2 cell line to anticancer drugs.
A-E: Sensitivity of CBC2T-2 cells to paclitaxel, gemcitabine, 5-fluorouracll, cisplatin, and oxaliplatin.
- Citation: Jiang NZ, Bai MZ, Huang CF, Ma ZL, Zhong RY, Fu WK, Gao L, Tian L, Mi NN, Ma HD, Lu YW, Zhang ZA, Zhao JY, Yu HY, Zhang BP, Zhang XZ, Ren YX, Zhang C, Zhang Y, Yue P, Lin YY, Meng WB. First report on establishment and characterization of the extrahepatic cholangiocarcinoma sarcoma cell line CBC2T-2. World J Gastroenterol 2023; 29(41): 5683-5698
- URL: https://www.wjgnet.com/1007-9327/full/v29/i41/5683.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i41.5683